GET READY. 💥🚀 PreveCeutical’s management team reported that the facility exceeded their expectations, and that they are advancing to the next stage of the due diligence process.
Stephen Van Deventer, PreveCeutical’s Chairman, Chief Executive Officer and President, stated, “We are pleased with the Penta 5 Group site visit and are moving forward with our due diligence using the data collected at the facility. We are encouraged by the scope of the Penta 5 Group facility’s diverse capabilities and how the addition of their five divisions and contract ready products could be applied to the future growth of PreveCeutical.”